ginsenoside Rf,
Ginsenoside Rf,
52286-58-5,
ginsenoside-rf,
UNII-JOS8BON5YW,
Panaxoside RF,
JOS8BON5YW,
CHEBI:67986,
MFCD00210509,
AC1L9BXN,
GINSENOSIDE- RF,
CHEMBL1773987,
Ginsenoside Rf, analytical standard,
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol,
HY-N0601,
AKOS027251120,
ZINC238809500,
CS-3841,
AN-41075,
SC-46561,
N1917,
X1153,
C08945,
286G585,
Q-100589,
Ginsenoside Rf, primary pharmaceutical reference standard,
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-,
(3|A,6|A,12|A)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-|A-D-glucopyranosyl-|A-D-glucopyranoside,
(3beta,6alpha,12beta)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside,
(beta,6alpha,12beta)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside,
GinsenosideRf,
C42H72O14,
CID441922,
ACN-035582,
C42-H72-O14,
C055328,
Ginsenoside Rf, 98%, from Panax ginseng C. A. Mey. - 5MG 5mg,
beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-beta-D-glucopyranosyl-,